iCo Therapeutics Extends Investor Relations Engagement with The Trout Group
VANCOUVER, Canada — iCo Therapeutics Inc. (TSX-V: ICO) (the "Company") today announced that it
VANCOUVER, Canada — iCo Therapeutics Inc. (TSX-V: ICO) (the "Company") today announced that it
For Immediate Release December 8, 2010 VANCOUVER, Canada — iCo Therapeutics Inc. (TSX-V: ICO)
VANCOUVER, Canada — iCo Therapeutics Inc. (TSX-V: ICO) (the "Company") today reported operational and
VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that the company
September 29, 2010 VANCOUVER, Canada— iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce
September 22, 2010 VANCOUVER , Canada — iCo Therapeutics Inc. (TSX-V: ICO) is pleased
August 27, 2010 VANCOUVER, Canada — iCo Therapeutics Inc. (TSX-V: ICO) (the "Company") today
July 26, 2010 VANCOUVER, Canada - iCo Therapeutics Inc. (TSXV: ICO) is pleased to
May 28, 2010 VANCOUVER, Canada - iCo Therapeutics Inc. (TSXV: ICO) ("iCo") is pleased
May 26, 2010 VANCOUVER, Canada — iCo Therapeutics Inc. (TSX-V: ICO) (the "Company") today